
Merck
Welcome to BIO! Below you'll find more information on the organization and resources to get involved.

MISSION - What we do
Drive a bio-revolution through Education, Collaboration, and Advocacy

PURPOSE - Why we do it
Cure patients, protect our climate and nourish humanity

VISION - What we will achieve
Rapid biotech innovation equitably harnessed for health, sustainability and justice
Michelle McMurry-Heath assumed the leadership of the Biotechnology Innovation Organization (BIO) as President and CEO on June 1, 2020. A medical doctor and molecular immunologist by training, Dr. McMurry-Heath becomes just the third chief executive to steward the world’s largest biotechnology advocacy group since BIO’s founding in 1993.


Get free access to 25 BIO Digital Sessions, including several with Merck scientists. Topics include a fireside chat with Dr. Fauci; Equity, Diversity, and Inclusion; COVID-19 Vaccine & Therapy Development; Patient Voice & Perspective.
Tracking all the industry's efforts on diagnostics, therapeutics and vaccines – including Merck.
Interactive pipeline tracker for all therapies and vaccines – there are nearly 550 programs!
A directory tracking the patient support programs available during coronavirus.
Designed to provide key information to keep your employees safe and business operating.
Designed to provide key scientific resources to advance development and manufacturing capacity.
Created to connect companies with capacity and resources with those that need them.
Provides an overview of how Agriculture & Environmental Biotech is responding to COVID-19.
Good Day BIO, the only daily newsletter at the intersection of biotech, politics, and policy. Subscribe to get it delivered to your inbox every weekday at 10 AM ET—and stay ahead of the news of the day.


BIO has launched a new campaign to tell the story of biotechnology through the eyes of those making a societal impact through science and those whose lives were changed forever because of scientific breakthroughs. Help us put a face to biotech and introduce the hidden heroes in our labs by sharing your story.

Antimicrobial resistance (AMR) is the evolution of deadly pathogens like bacteria and fungi to resist all current antimicrobial medicines. In this episode, we talk about how the dwindling supply of new antibiotics is fueling this silent pandemic, and why we need a continued pipeline of new antibiotics to avoid this crisis.
Subscribe on: Apple Podcasts, Google Podcasts, Spotify, or your player of choice.